T 0562/04 (Factor VIII/von Willebrand factor complex/OCTAPHARMA) of 14.2.2006

European Case Law Identifier: ECLI:EP:BA:2006:T056204.20060214
Date of decision: 14 February 2006
Case number: T 0562/04
Application number: 93902233.1
IPC class: C07K 1/18
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 93 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Process for recovering a high-purity virus-inactivated factor VIII/von Willebrand factor complex by anion exchanger chromatography
Applicant name: Octapharma AG
Opponent name: Baxter Healthcare S.A.
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 84
European Patent Convention 1973 Art 87(1)
European Patent Convention 1973 Art 88
European Patent Convention 1973 Art 89
European Patent Convention 1973 Art 111(1)
European Patent Convention 1973 Art 113(1)
European Patent Convention 1973 Art 114(2)
European Patent Convention 1973 Art 123(2)
European Patent Convention 1973 Art 123(3)
Keywords: Admissibility of late-filed documents - (yes)
Remittal - (no)
Main request - novelty (no)
Auxiliary request - added subject-matter, extension of scope of protection (no), clarity, novelty, sufficiency of disclosure, inventive step (yes)
Catchwords:

-

Cited decisions:
G 0002/98
T 0005/90
T 0019/90
T 1019/92
T 0649/97
Citing decisions:
-

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t040562eu1.html

Date retrieved: 17 May 2021

6 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law